Patent Grant
10487340
The present application is the National Phase under 35 U.S.C. § 371 of PCT International Application No. PCT/CN2015/091560, filed Oct. 9, 2015, which application is incorporated herein by reference in its entirety.
The present invention belongs to the technical field of plant protection, further belongs to the technical field of tobacco virus prevention and treatment, and particularly relates to a tobacco mosaic virus resistant N′au gene and cloning methods and applications thereof.
Tobacco mosaic virus (TMV) is an important tobacco disease, and the annual loss caused by it ranks forefront of the list of the top ten tobacco infectious diseases (Zhu Xianchao, 2002). There exist strain differentiations for TMV virus, such as TMV-Cg, TMV-U1 strain and the like, among which the TMV-U1 strain is the major strain of tobacco. Since the main cultivars of flue-cured tobacco such as K326, Yunyan 87 and the like are not resistant to TMV-U1 strain, generally, prevention and treatment measures such as cultivation of virus-free seedlings, chemical control and destruction of diseased plants in the field and the like are mainly taken. These measures have certain effects on controlling the occurrence and prevalence of TMV, but the cases of TMV prevail in a local field occur occasionally, leading to larger economic loss (Zhu Xianchao, 2002). Therefore, planting a TMV resistant variety is still the most fundamental and cost-effective mean for preventing and controlling TMV. The requirements for a disease-resistant variety include high resistance, no yield penalty and no agronomic traits disadvantages.
Currently, the TMV resistance resource of flue-cured tobacco is mainly from wild species of tobacco, Nicotiana glutinosa, the resistance of which is controlled by one dominant single gene (N). The N gene is resistant to TMV-U1 strain. N gene was cloned in 1994, which is the first NBS type of disease-resistant gene cloned in plants (Whitham, 1994). The length of the genome sequence of the N gene is 6,656 bp, including 5 exons and 4 introns, and belonging to a TIR-NBS-LRR type of disease-resistant genes. The N gene encodes a structure similar to the drosophila Toll protein and the extracellular domain of mammalian interleukin-1 receptor (Toll/interleukin-I receptor, TIR) on the N-terminal of the protein it encodes, and it also encodes a nucleotide-binding-site (NBS) and a leucine-rich repeat (LRR) domain (Whitham, 1994). The disease-resistant mechanism of N gene is that hypersensitive necrotic spots (necrotic spots) occur in the infected spots by virus, and the movement of TMV in a plant is limited by cell hypersensitive response caused by induction. After mediating the hypersensitive reaction, tobacco plants can obtain a systematic resistance, and produce a broad-spectrum resistance to the re-invasion of TMV or other similar pathogens (Whitham, 1994). By means of a series of conventional hybridization and backcrossing, the resistance of N gene is transferred from Nicotiana glutinosa into an oriental tobacco firstly, and then transferred into a flue-cured tobacco variety (Bagley, 2002). Transferring the resistance of N gene by using hybridization and breeding is actually transferring the chromosome segment carrying N gene (abbreviated as N introgression segment). Almost all the TMV resistant gene used by the breeding of TMV resistant flue-cured tobacco over the world is N gene. The representative varieties are TMV resistant flue-cured tobacco varieties Coker 176 and Speight H2O carrying N gene introgression segment, which are earlier commercially planted. Due to the linkage drags of lower yield, slower yellowing of the upper leaves, and so on, the flue-cured tobacco varieties carrying N gene could not meet the urgent need for leaf production. The linkage drags present in the chromosome segment derived from Nicotiana glutinosa which is closely linked to N gene, the narrow genetic background of the TMV resistant resources, which has been used for breeding, and the limitation of conventional breeding means, result in lacking breakthrough of TMV resistant flue-cured tobaccos breeding. Thus, the screening and identification of new TMV resistant gene in the tobacco germplasm resource bank is of great significance.
In addition, there is an N′ gene present in the wild tobacco varieties, and the corresponding avirulence gene is the coat protein (abbreviated as CP) gene of the virus of tobacco mosaic virus, belonging to CC-NBS-LRR type of disease-resistant genes (Sekine et al., 2012). N′ gene is resistant to TMV-Cg strain but not resistant to TMV-U1 strain.
For this, the present invention is intended to seek for a new gene resistant to TMV virus.
The first object of the present invention is to provide a tobacco mosaic virus resistant N′au gene; the second object is to provide a method for cloning the tobacco mosaic virus resistant N′au gene; the third object is to provide a polypeptide encoded by the tobacco mosaic virus resistant N′au gene; the fourth object is to provide an transient expression vector of the tobacco mosaic virus resistant N′au gene; the fifth object is to provide a method for constructing the transient expression vector of the tobacco mosaic virus resistant N′au gene; the sixth object is to provide applications of the tobacco mosaic virus resistant N′au gene; the seventh object is to provide a tobacco variety, a seed and an asexual propagule thereof obtained according to the applications of the tobacco mosaic virus resistant N′au gene; the eighth object is to provide an expression cassette comprising the tobacco mosaic virus resistant N′au gene; the ninth object is to provide a transgenic cell line comprising the tobacco mosaic virus resistant N′au gene; and the tenth object is to provide a recombinant strain comprising the tobacco mosaic virus resistant N′au gene.
The first object of the present invention is thus achieved with the base sequence of the tobacco mosaic virus resistant N′au gene as shown in SEQ ID No.1.
The second object of the present invention is thus achieved with the method for cloning the tobacco mosaic virus resistant N′au gene comprising the following steps:
respectively;
The third object of the present invention is thus achieved with the amino acid sequence of the polypeptide encoded by the tobacco mosaic virus resistant N′au gene as shown in SEQ ID No.2.
The fourth object of the present invention is thus achieved with the transient expression vector of the tobacco mosaic virus resistant N′au gene comprising N′au gene and vector pHellsgate 8.
The fifth object of the present invention is thus achieved with the method for constructing the transient expression vector of the tobacco mosaic virus resistant N′au gene being such that the vector pHellsgate 8 is digested by using restriction enzymes XhoI and XbaI, and the PCR amplification product of N′au recovered from gel is connected to the linear pHellsgate 8 vector by using a one-step seamless cloning kit.
The sixth object of the present invention is thus achieved with the application of the tobacco mosaic virus resistant N′au gene being such that a tobacco plant comprising N′au gene is obtained by a chromosome fragment introgression, or a gene introduction, or gene editing.
The seventh object of the present invention is thus achieved with the tobacco variety, seed and the asexual propagule thereof obtained according to the applications of the tobacco mosaic virus resistant N′au gene.
The eighth object of the present invention is thus achieved with the expression cassette comprising the tobacco mosaic virus resistant N′au gene.
The ninth object of the present invention is thus achieved with the transgenic cell line comprising the tobacco mosaic virus resistant N′au gene.
The tenth object of the present invention is thus achieved with the recombinant strain comprising the tobacco mosaic virus resistant N′au gene.
The N′au gene with resistance to both TMV-U1 and TMV-Cg strains provided by the present invention is of great application value. A tobacco variety with broad-spectrum resistance is cultivated by hybridization breeding, transgene, gene mutation and other means. A TMV resistant variety carrying N′au gene and having less linkage drag is easy to obtain by conventional breeding. Studies have found that there is highly homologous sequence of N′au gene in tobacco cultivated varieties such as Yunyan87 and the like, the introgression segment carrying N′au gene is prone to exchange with cultivars, and it is easy to obtain a single plantlet with shorter introgression segment carrying N′au gene. Therefore, a TMV resistant variety carrying N′au gene and having less linkage drag is easy to obtain by conventional breeding. In contrast, since the introgression segment of the wild tobacco variety Nicotiana glutinosa carrying N gene are longer, and the nucleotide homology with cultivated tobacco varieties, such as Yunyan87, is lower, the exchange of the introgression segment carrying N gene with cultivated varieties is difficult. A single strain with shorter introgression segment is difficult to obtain by conventional breeding. Therefore, it is difficult to obtain a TMV resistant variety carrying N gene and having less linkage drag.
A further illustration of the present invention will be described below in conjunction with the accompanying drawings; however, it's not intended to limit the present invention in any manner. Any change made based on the teachings of the present invention would fall within the protection scope of the present invention.
The base sequence of the tobacco mosaic virus resistant N′au gene of the present invention is shown as SEQ ID No.1. The N′au gene is a CC-NBS-LRR gene, not only resistant to TMV-U1 strain of tobacco mosaic virus, but also resistant to TMV-Cg strain.
According to the nucleotide sequence information shown as SEQ ID No.1 provided by the present invention, those skilled in the art can easily obtain a functionally equivalent gene by the following method: (1) by a genomic database search; (2) by screening the genomic library or cDNA library of tobacco with SEQ ID NO.1 as a probe; (3) by PCR amplification method from the genomic library or cDNA library of tobacco with oligonucleotide primers designed according to the sequence information of SEQ ID NO.1; (4) by modification via gene editing method on the basis of the sequence of N′ gene; (5) by a chemical synthesis method; and (6) by a deletion of codons of one or several amino acid residues and/or a mutation of one or several base pairs.
In addition, there may exist variants in nature having significant sequence identity with the polynucleotide as shown in SEQ ID NO.1 or the polypeptide as shown in SEQ ID NO.2 of the present invention. These variants may exist naturally, or may be artificially produced. Compared with the sequence as shown in SEQ ID NO.1, one or more nucleotides are deleted and/or added and/or substituted at one or more sites within the naturally occurring variants. Due to the degeneracy of genetic code, a conservative variant of polynucleotides also includes those sequences encoding the amino acid sequence of the polypeptide as shown in SEQ ID NO.2. The naturally occurring variants could be identified by the well-known molecular biology techniques, for example, by polymerase chain reaction (PCR) and hybridization technique known in the art. The variants produced artificially further include polynucleotides from the synthetic resources, such as a polynucleotide variant produced by site-directed mutagenesis, which still shares significant sequence identity with the naturally occurring sequence disclosed herein. As a result the resistance to the TMV-U1 strain is acquired. Typically, these variants have an identity rate of more than 95% with the sequence shown in SEQ ID NO.1.
The polynucleotide variant can also be evaluated by comparing the sequence shown as SEQ ID NO.2 with the amino acid sequence of the polypeptide encoded by the variant. The sequence identity rate between any two polypeptides could be calculated by sequence alignment programs and parameters. The identity percentage of the consensus sequence of two polypeptides is compared. In general, the sequence identity rate between two polypeptides encoded thereby should be above 95%.
The sequence identity rate may be calculated by using molecular biology methods such as MEGA, BLAST, etc.
In addition, the sequence shown as SEQ ID NO.1 can be isolated from other species of Nicotiana. The homology may be identified by PCR, hybridization, and other methods. According to the sequence identity with the nucleotide sequence shown as SEQ ID NO.1, or variants and segments thereof, sequences with the function of TMV-U1 strain resistance are isolated. Such kinds of sequences include an ortholog sequence of the sequence shown as SEQ ID NO.1. “Ortholog” is a gene derived from a common ancestral gene and found in different species as a result of the species formation. It is found in different species that genes which have a sequence identity of more than 95% in the nucleotide sequence thereof and/or the protein encoded thereby are considered as orthologs. The function of orthologs is often highly conservative among species.
The method of cloning the tobacco mosaic virus resistant N′au gene of the present invention comprising following steps:
respectively;
The total volume of the PCR reaction system is 50 μL, containing 4.0 μL of 100 ng/μL DNA sample, 10.0 μL of 5×PCR buffer, 4 μL of dNTPs (2.5 mmol/L each), 2.0 μL of 10 μmol/L primer N′-H8-F and N′-H8-R each, 1 μL of PrimeSTAR GXL DNA Polymerase, and 27 μL of ddH2O. The reaction condition of the PCR is 98° C., 2 min; 38 cycles of 98° C., 10 s, 52° C., 15 s, 68° C., 5 min; and 68° C., 10 min.
The method of the sequencing can be direct sequencing, and can also be the cloning sequencing by TA vector.
The amino acid sequence of the polypeptide encoded by the tobacco mosaic virus resistant N′au gene of the present invention is shown as SEQ ID No.2.
The transient expression vector of the tobacco mosaic virus resistant N′au gene of the present invention comprises N′au gene and vector pHellsgate 8. The method for constructing the transient expression vector is such that the vector pHellsgate 8 is digested by using restriction enzymes XhoI and XbaI, and a PCR amplification product of N′au gene recovered from gel is connected to the linear pHellsgate 8 vector using a one-step seamless cloning kit. As a preferred embodiment of the invention, the one-step seamless cloning kit is One Step Cloning Kit ClonExpress™ II.
An application of the tobacco mosaic virus resistant N′au gene of the present invention is to obtain a tobacco plant comprising N′au gene by a chromosome segment introgression, a gene introduction and/or gene editing. The method of chromosome segment introgression comprises hybridization breeding, protoplasts fusion and/or introgression of chromosome segment into substitution lines or introgression lines to transfer into the target tobacco, thus obtaining a new Tobacco mosaic virus resistant variety. Firstly, a germplasm resource comprising N′au gene is obtained by screening from Nicotiana plants, by using a functional molecular marker or a linked molecular marker associated with the sequence shown as SEQ ID NO.1, or by artificial inoculation of TMV; the germplasm resource comprises wild species of cultivated tobacco, a cultivated cultivar of tobacco, and a hybrid cultivar of wild species and a cultivated cultivar of tobacco. Then, such tobacco material having increased-resistance is bred to be a commercial variety to improve the TMV resistance of main tobacco cultivars by hybridization, backcrossing and other breeding means.
The gene introgression relates to introducing an exogenous resistance gene into a target tobacco, including an introduction after the transferring of the exogenous gene (i.e., transgene) and a direct introduction. The most commonly used method for transgene is Agrobacterium transformation method. The method of direct introduction includes conventional biological methods such as microscope injection, pollen tube pathway, conductivity, gene gun, and the like to transform tobacco cells or tissues. The transformed tissues are cultivated into a plant.
Gene editing is a recently developed technique which can accomplish the accurate modification to a genome, which can accomplish site-directed InDel mutation, knock-in, simultaneous mutation on multiple sites, and deletion of small segments of gene, etc., and can perform accurate gene editing at genomic level. Accurate gene editing performed on the homologue of N′au gene allows the edited homologue to obtain the function of resistance to TMV-U1 and TMV-Cg strain.
A new TMV resistant tobacco variety, seeds and asexual propagules thereof can be obtained, depending on the application of the tobacco mosaic virus resistant N′au gene. In addition, some genetic engineering products including an expression cassette, a transgenic cell line and a recombinant strain, etc., of the resistant tobacco mosaic virus can also be developed.
Further explanation and verification will be given below in combination with examples.
Unless otherwise specified, the methods used in the following examples were all conventional methods. If there is no special specification, the experimental materials used were all purchased from conventional biochemical reagent companies. The tobacco materials were N. sylverstris (PI555569), N. alata (PI42334), N. benthamiana, Coker176, and K326, which are all from Yunnan Tobacco Agricultural Science Research Institute. TMV-U1 and TMV-Cg strain virus were from Yunnan Tobacco Agricultural Science Research Institute. The cDNA of TMV-U1 and TMV-Cg were obtained by a conventional method of the reverse transcription of total RNA extracted from virus-infected tobacco leaves by conventional methods.
Gateway LR clonase Enzyme Mix kit and pENTR2B vector were purchased from Invitrogen Corporation, and Agrobacterium GV3101 was purchased from Invitrogen Corporation. The pHellsgate8 vector was purchased from Thermofisher Company. Plasmid DNA extraction kit, Agarose gel DNA recovery kit, and DNA fragment purification kit were purchased from QIAGEN Company. Escherichia coli DH5a, restriction enzymes, reverse transcription kit, DNA Marker, PrimeSTAR GXL DNA Polymerase, T4 DNA polymerase and T4 DNA ligase, and spectinomycin were all purchased from Takara (Dalian) Company and Roche Company. RNA extraction kit Trizol was purchased from Invitrogen Corporation, and ELISA kits for detecting TMV and Immunostrips were purchased from Agdia Company.
The culture and inoculation method of Agrobacterium: Agrobacterium tumefaciens GV3101 was transformed with a transient expression vector plasmid. The positive clones were activated by a shake culture in 2 mL LB antibiotics (50 mg/L rifampicin, and 50 mg/L spectinomycin) medium, at 28° C., at 210 r/min for 30 hours. 150 μL activated bacteria solution was added to 10 mL LB medium (containing 10 mmol/L morpholine ethane sulfonic acid (MES) (pH 5.6), 40 μmol/L acetosyringone, 50 mg/L rifampicin, and 50 mg/L spectinomycin). After cultivated at 28° C., at 210 r/min for 16 hours, the bacteria was collected by a centrifugation at 4700 r/min for 5 minutes. The bacteria was resuspended and adjusted to a bacteria solution with an OD600=0.6 by using infiltration buffer (10 mmol/L MgCl2, 10 mmol/L MES, 200 μmol/L acetosyringone). After kept at room temperature for 3 hours, the 4-week old tobacco seedling leaf was infiltrated with a 2 mL syringe. After inoculation, the tobacco seedling was cultivated in a light culturing room at 25˜28° C. for 7 days and the hypersensitive response (HR reaction) was surveyed and observed.
(1) TMV-U1 Strain Resistant N. alata (PI42334), with a Resistance Different from N Gene
15 plants for each of the four kinds of tobaccos variety such as N. sylverstris (PI555569), N. alata (PI42334), Coker176, and K326 were planted (potted). When there were 4-5 leaves, each was inoculated with TMV-U1 strain and a blank control. The symptoms on the 5th, 7th and 14th day after inoculation were surveyed and recorded.
The result on 7th day after inoculation of virus shows that N. alata (PI42334) and Coker176 are TMV-U1 strain resistant, and N. sylverstris and K326 are susceptible to TMV-U1 strain (Table 1,
N. alata
N. sylverstris
It has been reported in the literature that there is a TMV-U1 strain resistant N gene in Coker176, and specific molecular markers N1/N2 and E1/E2 for detecting N gene have been developed (Lewis, 2005). In order to verify the relationship between the disease-resistant genes in N. alata (PI42334) and N gene, leaves from the four kinds of tobacco varieties were taken, the DNA from each was extracted by QIAGEN kit, and PCR detection was performed by using specific molecular markers N1/N2 and E1/E2 of N gene. The result (Table 1,
(2) Confirmation of TMV-U1 Resistant Avirulence Gene of N. alata (PI42334)
Construction of a transient expression vector of TMV-U1 and TMV-Cg CP gene: transient expression vectors of coat proteins (abbreviated as CP) gene of TMV-U1 and TMV-Cg strain were constructed by using a modified vector pHellsgate8. The following primer pairs were used to amplify the viral cDNA of the CP genes of TMV-U1 and TMV-Cg strain:
The amplified fragment is inserted into pHellsgate8 vector according to the method of pHellsgate8 vector kit protocol. The attB sites are amplified by using the following primer pairs:
The amplified fragment is inserted into pDONR221 vector (Invitrogen) according to the method of pDONR221 vector (Invitrogen) kit for BP reaction protocol, and then inserted into expression vector pHellsgate8 by using LR reaction of Gateway® technique.
To determine the avirulence gene in N. alata (PI42334) interacting with TMV-U1 strain, the transient expression vectors Agrobacterium of TMV-U1 CP and TMV-Cg CP and a blank vector Agrobacterium control were used to inoculate the tobacco with a 2 mL syringe. Before inoculation, a suitable tobacco leaf was uniformly punched with a syringe needle. Five plants for each of the N. sylverstris (PI555569), N. alata (PI42334), Coker176 and K326 during 4˜5 leaves period were infiltrated and inoculated. The largest 2 leaves of each plant were inoculated. The plants were cultivated in dark for 1˜2 days after inoculation, and HR reaction was investigated on the 7th, 10th day at 28° C. in a light culturing room.
The result (Table 2,
N. alata
N. sylverstris
(1) Extraction of the total DNA of tobacco: a fresh tobacco leaf was taken, and the total genomic DNA of tobacco was extracted by using QIAGEN DNeasy Plant Mini kit. DNA quality was preliminarily detected by using UV spectrophotometry (Nanodrop) and Agarose gel electrophoresis method. DNA samples with acceptable quality were diluted to 100 ng/μL by using 0.5×TE solution, and preserved until ready for use.
(2) Cloning of N′au gene: PCR amplification was performed by using the DNA of N. alata (PI42334) or N. sylvestris (PI555569) as a template, and using primer N′-H8-F (5′-ATGGAGATTGGCTTAGCAGT-3′ (SEQ ID NO.3)) and primer N′-H8-R (5′-TCACAGGCATTCACAATCGA-3′ (SEQ ID NO.4)). The total volume of PCR reaction system is 50 μL, containing 4.0 μL of 100 ng/μL DNA sample, 10.0 μL of 5×PCR buffer, 4 μL of dNTPs (2.5 mmol/L each), 2.0 μL of 10 μmol/L primer N′-H8-F and N′-H8-R each, 1 μL of PrimeSTAR GXL DNA Polymerase, and 27 μL of ddH2O. The reagents used were purchased from Takara Bio. The reaction condition for PCR is 98° C., 2 min; 38 cycles of 98° C., 10 s, 52° C., 15 s, 68° C., 5 min; and 68° C., 10 min.
(3) Recovery and purification of PCR product: The PCR product was electrophoresed through 1.5% Agarose gel. The electrophoresis buffer was 1×TAE. When the electrophoresis indicator bromophenol blue migrated sufficiently to separate DNA fragments under the condition of 120V for 60 minutes, the gel was taken down. The result was recorded by using gel image analysis system, as shown in
(4) PCR product sequencing: The PCR product from gel recovery was sent to Takara Bio for sequencing. The DNA sequence of N′au gene is shown as SEQ ID No.1 in the sequence list, and the open reading frame is from the Pt to the 4143th position at the 5′ end of the sequence of SEQ ID No.1 in the sequence list.
According to the nucleotide sequence of N′au gene, the amino acid sequence of the polypeptide encoded by the N′au gene, which is deduced by using molecular biology software MEGA6, is shown in SEQ ID No.2.
Vector pHellsgate 8 was digested by using restriction enzymes XhoI and XbaI. The amplification products of N′au and N′ recovered from gel were linked to linear vector pHellsgate 8 by using One Step Cloning Kit ClonExpress™ II (Vazyme, Nanjing, China).
To determine that the N′au gene in N. alata (PI42334) has the biological function of TMV-U1 and TMV-Cg resistance, the Agrobacterium transient expression vector of N′au and N′ were constructed. The construction of transient expression vector of N′au was the same as that in Example 4, and the construction of the transient expression vector of N′ was the same as that in Example 4.
After the accomplishment of construction, a combination of the following transient expression vectors was infiltrated and inoculated by using Agrobacterium: N′au+U1 CP; N′au+CgCP; N′au+BLK. N′+U1CP; N′+CgCP; N′+BLK, wherein BLK is a blank transient expression vector. N. benthamiana, a wild tobacco variety was infiltrated and inoculated. 10 plants of N. benthamiana were inoculated during 4˜5 leaves period, and the largest 2 leaves of each plant were inoculated. The HR reaction was investigated on the 7th and the 10th day.
The result suggests that (Table 3,
The chromosome segments comprising N′au gene shown as SEQ ID NO.1 in Nicotiana plants were transferred into the target tobacco by conventional breeding method. By using a functional molecular marker or a linked molecular marker of N′au, or method of artificial inoculation of TMV, the germplasm resource comprising N′au gene was obtained by screening from Nicotiana plants. The germplasm resource comprises wild species of cultivated tobacco, a hybrid cultivar of wild species and a cultivated cultivar of tobacco, and a cultivated cultivar of tobacco. The chromosome segments comprising N′au gene in the germplasm resource were introduced into the target tobacco to obtain the non-transgenic tobacco materials with increased TMV resistance by using conventional crossbreeding or protoplast fusion or introduction of chromosome segments or other technical means. Such resistance-increased tobacco materials were bred to be a commercial variety to improve the TMV resistance in a main cultivated variety by hybridization, backcrossing and other breeding means.
The homologue of N′au gene in the target tobacco acquired a function equivalent to N′au by biotechnology modification. Tobacco with increased resistance was obtained. The homologue of N′au gene in the target tobacco was obtained by cloning. The nucleotide sequence and amino acid sequence of the homologue of N′au gene were obtained by sequencing. The difference between the homologue of N′au gene and the N′au in the nucleotide and amino acid sequence was found by sequence alignment analysis. The key different nucleotides which determine that the N′au is TMV-U1 strain resistant while the homology of N′au gene is TMV-U1 strain susceptible were found by means such as PCR mutation, and inoculation by co-infiltrating with TMV-U1 CP Agrobacterium transient expression vector, etc. By using molecular biology techniques such as mutagenesis, gene editing and the like, the key different nucleotides of the homologue of N′au gene were modified to be the polynucleotide sequence corresponding to N′au gene, such that the modified homologue of N′au gene acquires the function of TMV-U1 strain resistance.
In summary, N′au gene is a new disease-resistant gene which is not only different from N gene, but also different from N′ gene, and it can be both TMV-U1 strain resistant and TMV-Cg strain resistant. Thus, there is broad application prospect in actual production.
| Filing Document | Filing Date | Country | Kind |
|---|---|---|---|
| PCT/CN2015/091560 | 10/9/2015 | WO | 00 |
| Publishing Document | Publishing Date | Country | Kind |
|---|---|---|---|
| WO2017/059582 | 4/13/2017 | WO | A |
| Number | Date | Country |
|---|---|---|
| 1157549 | Aug 1997 | CN |
| Entry |
|---|
| International Search Report and Written Opinion dated Jul. 14, 2016 for Application No. PCT/CN2015/091560. |
| Genbank Submission; NIH/NCBI, Accession No. AB669000. Sekine et al., Sep. 3, 2013. 3 pages. |
| Genbank Submission; NIH/NCBI, Accession No. BAM17521. Sekine et al., Sep. 3, 2013. 3 pages. |
| Zhang et al., Tobacco N Gene and Its Application in Genetic Breeding. Chin. Agr. Sci. Bull. Jul. 31, 2013; 29(19): 89-92. |
| Laskowska et al., Cytology and fertility of viable hybrids of Nicotiana tabacum L. cv. TB-566 with N. alata Link et Otto. J Appl Genet. 2005;46(1):11-8. |
| Nikova et al., Nicotiana tabacum L. as a source of cytoplasmic male sterility in interspecific cross with N. alata Link & Otto. Euphytica. 1999;107:9-12. |
| Number | Date | Country | |
|---|---|---|---|
| 20180016595 A1 | Jan 2018 | US |
